ATE54009T1 - Molekulare klone des genoms von htlv-iii. - Google Patents

Molekulare klone des genoms von htlv-iii.

Info

Publication number
ATE54009T1
ATE54009T1 AT85305878T AT85305878T ATE54009T1 AT E54009 T1 ATE54009 T1 AT E54009T1 AT 85305878 T AT85305878 T AT 85305878T AT 85305878 T AT85305878 T AT 85305878T AT E54009 T1 ATE54009 T1 AT E54009T1
Authority
AT
Austria
Prior art keywords
htlv
aids
iii
clones
molecular clones
Prior art date
Application number
AT85305878T
Other languages
English (en)
Inventor
Flossie Wong-Staal
Robert C Gallo
Beatrice H Hahn
Mikulas Popovic
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE54009T1 publication Critical patent/ATE54009T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT85305878T 1984-08-22 1985-08-19 Molekulare klone des genoms von htlv-iii. ATE54009T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64330684A 1984-08-22 1984-08-22
EP85305878A EP0173529B1 (de) 1984-08-22 1985-08-19 Molekulare Klone des Genoms von HTLV-III

Publications (1)

Publication Number Publication Date
ATE54009T1 true ATE54009T1 (de) 1990-07-15

Family

ID=24580229

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85305878T ATE54009T1 (de) 1984-08-22 1985-08-19 Molekulare klone des genoms von htlv-iii.

Country Status (10)

Country Link
EP (1) EP0173529B1 (de)
JP (1) JPH0789931B2 (de)
AT (1) ATE54009T1 (de)
AU (1) AU580094B2 (de)
CA (1) CA1341366C (de)
DE (1) DE3578340D1 (de)
IE (1) IE59401B1 (de)
IL (1) IL76082A (de)
NZ (1) NZ213155A (de)
WO (1) WO1986001535A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8423659D0 (en) * 1984-09-19 1984-10-24 Pasteur Institut Cloned dna sequences
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
DE3587512T2 (de) 1984-10-18 1993-12-02 Centre Nat Rech Scient Hüllenantigene vom menschlichen Immunodefizienz-Virus und deren Verwendungen.
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
US7285271B1 (en) 1984-10-31 2007-10-23 Novartis Vaccines And Diagnostics, Inc. Antigenic composition comprising an HIV gag or env polypeptide
US7393949B1 (en) * 1987-12-24 2008-07-01 Novartis Vaccines And Diagnostics, Inc. Human immunodeficiency virus (HIV) nucleotide sequences
US7273695B1 (en) 1984-10-31 2007-09-25 Novartis Vaccines And Diagnostics, Inc. HIV immunoassays using synthetic envelope polypeptides
EP0187041B1 (de) * 1984-12-24 1996-05-15 Genentech, Inc. Fusionen von AIDS-verwandten Polypeptiden
US6534285B1 (en) 1984-12-24 2003-03-18 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
US5853978A (en) * 1985-12-04 1998-12-29 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
US5008182A (en) * 1986-01-10 1991-04-16 Cetus Corporation Detection of AIDS associated virus by polymerase chain reaction
US5176995A (en) * 1985-03-28 1993-01-05 Hoffmann-La Roche Inc. Detection of viruses by amplification and hybridization
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
US5773210A (en) * 1985-04-19 1998-06-30 The United States Of America As Represented By The Department Of Health And Human Services Acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS
GR862412B (en) * 1985-09-25 1987-01-23 Oncogen Vaccines and immuinoassays for acquired immune deficiency syndrome
FR2593519B1 (fr) * 1985-09-25 1994-01-07 Oncogen Vaccin contre le syndrome immunodeficitaire acquis et intermediaires pour la preparation de ce vaccin
JPS62502868A (ja) * 1985-12-24 1987-11-19 アメリカ合衆国 ヒトｔリンパ球指向性ウイルスタイプ３のプラスミド及びファ−ジクロ−ン
AU605478B2 (en) * 1986-01-31 1991-01-17 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Sor gene product from human t-cell lymphotropic virus iii
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0242216A1 (de) * 1986-04-16 1987-10-21 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Nicht cytopathischer Klon von menschlichem T-Zellen lymphotropen Virus Typ-III
FR2600342B1 (fr) * 1986-06-19 1989-11-17 Eurobio Lab Procede pour le depistage, chez les individus seropositifs, des sequences d'adn du retrovirus htlv iii-lav et coffret pour sa mise en oeuvre
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
US5079351A (en) * 1986-11-26 1992-01-07 Cetus Corporation Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization
US5268268A (en) * 1986-11-26 1993-12-07 Hoffmann-La Roche Inc. Detection of HTLVI and HTLVII viruses by hybridization
US5141867A (en) * 1987-02-02 1992-08-25 E. I. Du Pont De Nemours And Company Nucleotide sequence encoding a human immunodeficiency virus antigen
US4861707A (en) * 1987-02-02 1989-08-29 E. I. Du Pont De Nemours And Company Human immunodeficiency virus antigen
US5622820A (en) * 1988-03-10 1997-04-22 City Of Hope Method for amplification and detection of RNA and DNA sequences
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US6235479B1 (en) 1999-04-13 2001-05-22 Bio Merieux, Inc. Methods and devices for performing analysis of a nucleic acid sample

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401756A (en) * 1981-04-14 1983-08-30 Immunex Corporation Process for preparing human interleukin 2
JPS59104325A (ja) * 1982-12-07 1984-06-16 Japan Found Cancer ヒト白血病ウイルスの遺伝子ｒｎａに相補性を示すｄｎａ
GB8423659D0 (en) * 1984-09-19 1984-10-24 Pasteur Institut Cloned dna sequences
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
US4652599A (en) * 1984-04-23 1987-03-24 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells
NZ228756A (en) * 1984-04-23 1990-10-26 Us Health Detection of hiv antigen using competition immune assay or western blot assay
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
JPS62502868A (ja) * 1985-12-24 1987-11-19 アメリカ合衆国 ヒトｔリンパ球指向性ウイルスタイプ３のプラスミド及びファ−ジクロ−ン

Also Published As

Publication number Publication date
CA1341366C (en) 2002-06-11
AU580094B2 (en) 1988-12-22
DE3578340D1 (de) 1990-07-26
IL76082A0 (en) 1985-12-31
IL76082A (en) 1991-07-18
EP0173529A1 (de) 1986-03-05
JPS61501431A (ja) 1986-07-17
IE852056L (en) 1986-02-22
AU4776585A (en) 1986-03-24
IE59401B1 (en) 1994-02-23
JPH0789931B2 (ja) 1995-10-04
NZ213155A (en) 1989-02-24
WO1986001535A1 (en) 1986-03-13
EP0173529B1 (de) 1990-06-20

Similar Documents

Publication Publication Date Title
DE3578340D1 (de) Molekulare klone des genoms von htlv-iii.
FI872093L (fi) Haordmetall med bindemedelsfasgradient och foerfarande foer framstaellning av den.
DK224286D0 (da) 2',3'-dideoxy-nucleosider
SE8704298D0 (sv) Compounds for use in therapy
DE3784693D1 (de) Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
DK0391088T3 (da) Anvendelse af funktionelle derivater af det intercellulære adhæsionsmolekyle ICAM-1 til antiviral terapi
EP0261224A4 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
NO872462D0 (no) Fremgangsmaate for fremstilling av kondenserte, cykliske azepin-2-on-derivater.
ATE68349T1 (de) Medizinische verwendung von nukleosiden.
FI875544A7 (fi) 3'-deoksitymidin-2'-eenin (3'-deoksi-2',3'-didehydrotymidiini) käyttö retroviruksilla infektoituneiden potilaiden hoitoon.
NO168654C (no) Fremgangsmaate for polymerisering av 1,3-butadien.
NO871862D0 (no) Fremgangsmaate for paavisning av aids-virusinfeksjon.
FI874166A7 (fi) 2',3'-dideoksisytidin-2'-eenin käyttö retroviruksilla infektoituneiden potilaiden hoitoon.
NO893062D0 (no) Anvendelse av isokinolinforbindelser, saerlig i inhalasjonspreparater.
DE3774347D1 (de) Sechsgliedrige heterocyclische derivate von n'-substituierten n,n'-diacylhydrazinen.
FI872960L (fi) Expression av en gen av aids-virus.
ATE83481T1 (de) Fuenfgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
ATE36325T1 (de) Derivate von 5-halovinyl-2'-deoxyuridin.
FI872938A0 (fi) Kraftanlaeggning med foerbraenning av ett braensle i en fluidiserad baedd.
ES2058542T3 (es) Imidas biciclicas puenteadas de 4-(4-(3-benzoisotiazolil)-1-piperazinil)butilo antipsicoticas.
DE3785272D1 (de) Derivate von 2,2-dimethylcyclopropancarbonsaeure.
DK595885A (da) Fremgangsmaade og cellelinie til kontinuerlig dannelse af retrovirus(htlv-iii) beslaegtet med aids
SU1610831A1 (ru) Производные 1-бензил-4,5,6,7-тетрагидротриазоло[4,5-c]пиридина, обладающие гипотензивными, спазмолитическими и нейротропными свойствами
RO91884B (ro) Procedeu pentru prepararea unor derivati esterici de difenileteroxima
ATE55257T1 (de) Verfahren zur herstellung von hochgereinigten, hepatitis-b-virus-infektionsfreien gammaglobulinen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time